Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Salido

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Oncotarget|June 5, 2015
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)David Casadevall, Javier Gimeno, Sergi Clavé, et al.
The Prostate|September 17, 2021
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrenceSilvia Hernández-Llodrà, Laura Segalés, Nuria Juanpere, et al.
Clinical Lung Cancer|April 17, 2018
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung AdenocarcinomaÁlvaro Taus, Laura Camacho, Pedro Rocha, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2019
Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinomaJoan Gibert, Sergi Clavé, Max Hardy-Werbin, et al.
Archivos De Bronconeumologia|April 8, 2020
Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung AdenocarcinomaÁlvaro Taus, Laura Camacho, Pedro Rocha, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Identification of male cardiomyocytes of extracardiac origin in the hearts of women with male progeny: male fetal cell microchimerism of the heartAntoni Bayes-Genis, Beatriz Bellosillo, Oscar de la Calle, et al.
Cancer Genetics|May 8, 2012
Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array studyAlma Carracedo, Marta Salido, Josep M Corominas, et al.
The Journal of Urology|September 25, 2012
MYC copy number gains are associated with poor outcome in penile squamous cell carcinomaEmili Masferrer, Carla Ferrándiz-Pulido, Belén Lloveras, et al.
Oncotarget|January 20, 2016
ROS1 copy number alterations are frequent in non-small cell lung cancerSergi Clavé, Javier Gimeno, Ana M Muñoz-Mármol, et al.
Archives of Pathology & Laboratory Medicine|November 10, 2022
MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell SarcomasGerard Frigola, Marco Bühler, Marta Marginet, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Oncotarget|June 5, 2015
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)David Casadevall, Javier Gimeno, Sergi Clavé, et al.
The Prostate|September 17, 2021
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrenceSilvia Hernández-Llodrà, Laura Segalés, Nuria Juanpere, et al.
Clinical Lung Cancer|April 17, 2018
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung AdenocarcinomaÁlvaro Taus, Laura Camacho, Pedro Rocha, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2019
Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinomaJoan Gibert, Sergi Clavé, Max Hardy-Werbin, et al.
Archivos De Bronconeumologia|April 8, 2020
Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung AdenocarcinomaÁlvaro Taus, Laura Camacho, Pedro Rocha, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Identification of male cardiomyocytes of extracardiac origin in the hearts of women with male progeny: male fetal cell microchimerism of the heartAntoni Bayes-Genis, Beatriz Bellosillo, Oscar de la Calle, et al.
Cancer Genetics|May 8, 2012
Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array studyAlma Carracedo, Marta Salido, Josep M Corominas, et al.
The Journal of Urology|September 25, 2012
MYC copy number gains are associated with poor outcome in penile squamous cell carcinomaEmili Masferrer, Carla Ferrándiz-Pulido, Belén Lloveras, et al.
Oncotarget|January 20, 2016
ROS1 copy number alterations are frequent in non-small cell lung cancerSergi Clavé, Javier Gimeno, Ana M Muñoz-Mármol, et al.
Archives of Pathology & Laboratory Medicine|November 10, 2022
MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell SarcomasGerard Frigola, Marco Bühler, Marta Marginet, et al.
Pageof 11